Status: current, Defined. Date: 30-Nov 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1731281000168112 | bicalutamide 50 mg tablet [84 tablets] (&) inert substance diluent [1 syringe] (&) leuprorelin acetate 22.5 mg modified release injection [1 x 22.5 mg syringe], 1 pack (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1731291000168110 | leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | Is a | bicalutamide 50 mg tablet, 84 | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | Is a | leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | has MPUU | bicalutamide 50 mg tablet | true | Inferred relationship | Some | 3 | |
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | has MPUU | leuprorelin acetate 22.5 mg modified release injection, syringe | true | Inferred relationship | Some | 2 | |
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | has MPUU | inert substance diluent, syringe | true | Inferred relationship | Some | 1 | |
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | has component pack | bicalutamide 50 mg tablet, 84 | true | Inferred relationship | Some | ||
| leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | has component pack | leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 84 x Bicalutamide (MPL) tablets), 1 pack | Is a | True | leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | Inferred relationship | Some | |
| Bi Eligard CP 3 Month (1 x Eligard 3 Month pack, 84 x Bicalutamide (Tolmar) tablets), 1 pack | Is a | True | leuprorelin acetate 22.5 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe] (&) bicalutamide 50 mg tablet [84], 1 pack | Inferred relationship | Some |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR